Remove Development Remove Engineer Remove Research
article thumbnail

Researchers develop CRISPR-based drug candidate for microbiome targeting

Pharmaceutical Technology

The Technical University of Denmark (DTU) has announced that an international scientific team has developed a CRISPR-based drug candidate that targets E coli directly and leaves the microbiome intact. The research team has designed four bacterial viruses which use CRISPR technology to kill the unwanted bacteria precisely.

article thumbnail

UTA engineer develops automatic crack evaluation system for roads, bridges, runways

Scienmag

A civil engineering researcher at The University of Texas at Arlington will utilize a $122,000 grant to develop an automatic crack evaluation (ACE) system that could save time and money and prioritize maintenance for roads, bridges and runways.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Keysight and Singapore’s Quantum Engineering Programme to accelerate research, development and education in quantum technologies

Scienmag

NYSE: KEYS), a leading provider of advanced design and validation solutions, and Singapore’s Quantum Engineering Programme (QEP) have signed a Memorandum of Understanding (MOU) to collaborate in accelerating research, development and education in quantum technologies. Keysight Technologies, Inc.

article thumbnail

ElevateBio and Affini-T collaborate to develop T cell therapies

Pharmaceutical Technology

ElevateBio has entered a partnership with Affini-T Therapeutics to progress the latter’s engineered TCR-T therapies focused on Kirsten rat sarcoma viral oncogene homolog (KRAS), a dominant oncogenic driver mutation in solid tumours. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

article thumbnail

Capsida Biotherapeutics and Prevail to develop CNS gene therapies

Pharmaceutical Technology

Capsida Biotherapeutics and Eli Lilly and Company ’s wholly owned subsidiary Prevail Therapeutics have announced a partnership for the development of non-invasive gene therapies for central nervous system (CNS) diseases.

article thumbnail

Engineering researchers receive $1 million NSF grant for first networked-AI testbed

Scienmag

A new generation of networked, cooperating robots being developed by researchers in the Center for Connected Autonomy and Artificial Intelligence (ca-ai.fau.edu) at Florida Atlantic University’s College of Engineering and Computer Science and Institute for Sensing and Embedded Network Systems Engineering (I-SENSE) is all about “teamwork.”

article thumbnail

City of Hope researchers develop new brain cancer therapy

Pharmaceutical Technology

Researchers at City of Hope in the US have developed a new potential therapy to treat glioblastoma multiforme (GBM), a kind of brain cancer. These viruses are engineered genetically for killing cancer. The post City of Hope researchers develop new brain cancer therapy appeared first on Pharmaceutical Technology.